Flagship Pioneering Fund VI General Partner LLC
Insider CIK 1724957 · MCRB 10% owner · SANA 10% owner · OMGA 10% owner · GENB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 843,881 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,531,644 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,953,586 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,500,000 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 17,016,215 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 18,483,785 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 4,340,252 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 15,264,724 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 1,562,500 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 13,702,224 | — | $0 | 13,702,224 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 12,723,940 | — | $0 | 12,723,940 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 987,491 | — | $0 | 987,491 | SEC↗ |
| GENB Generate Biomedicines, Inc | A Award deriv | 2026-02-26 | 2026-03-02 | 29,561 | — | $0 | 29,561 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 345,069 | — | $0 | 1,035,208 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,431,281 | — | $0 | 7,293,841 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 1,181,745 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 4,926,378 | — | $0 | 8,057,470 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 70,813 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,825,989 | — | $0 | 8,615,337 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 13,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 22,275,232 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 4,112,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,666 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 27,388,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 970,588 | — | $0 | 970,588 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,323,529 | — | $0 | 1,323,529 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 661,764 | $17.00 | $11.25M | 5,514,707 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 4,852,943 | — | $0 | 4,852,943 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 294,117 | $17.00 | $5.00M | 1,617,646 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 220,588 | $17.00 | $3.75M | 8,617,413 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 8,396,825 | — | $0 | 8,396,825 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 5,896,386 | — | $0 | 5,896,386 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,088,470 | — | $0 | 1,088,470 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 1,487,371 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 9,725,122 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 11,441,326 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 11,585,199 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 3,587,820 | — | $0 | 4,434,600 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 642,180 | — | $0 | 1,283,282 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 966,234 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,186,310 | — | $0 | 3,258,134 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,481,481 | — | $0 | 2,962,963 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 43,154 | — | $0 | 0 | SEC↗ |